Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness
Open Access
- 4 November 2022
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 16, 3847-3864
Abstract
Purpose: The objective of the present study was to scrutinize the microsponges (MS) as a carrier system using Adapalene (ADA) as a model drug. Methods: Data modelling was implemented using Plackett-Burman design to identify the main variables affecting the formulation of ADA-MS. The adopted method of preparation for MS was quasi-emulsion solvent diffusion method. The nominated independent variables were volume of organic phase, sonication time, stirring speed, drug percent, polymer type, emulsifier concentration, and method of organic phase addition. As for the dependent variables, they included entrapment efficiency (E.E.%), production yield (P.Y.%), particle size (P.S.) and morphology. Furthermore, selected ADA loaded microsponges (ADA-MS) were in vitro assayed for their biological activities via cytotoxicity, UVA irradiation and cell viability, and antimicrobial activity. Results: The study indicated that the drug percent, polymer type and surfactant concentration have the key significant effect on E.E.% and P.Y.%, while, the drug percent, stirring speed and volume of organic phase have had a significant effect on P.S. and their morphology. Furthermore, ADA-MS had a momentous cytotoxic effect on A431 and M10 cell-lines with exceptional enrichment when the polymer Eudragit RS100 was used. Also, the ADA-MS increased the cell viability after UVA irradiation on HFB-4 cell-line by 14% to 43%, especially when using Ethyl Cellulose as a polymer. Lastly, the antimicrobial activity of ADA against Propionibacterium acnes was boosted when incorporated into MS. Conclusion: The Plackett−Burman design proved its impact in discerning preparation variables affecting the quality of ADA-MS formulation, with heightening of the in vitro biological activities of ADA. Thus, MS was presumed to be an auspicious carrier system for ADA. Graphical Abstract:Keywords
This publication has 51 references indexed in Scilit:
- Clinical efficacy of adapalene (Differin®) 0.3% gel in Chilean women with cutaneous photoagingJournal of Dermatological Treatment, 2011
- Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett–Burman designInternational Journal of Pharmaceutics, 2010
- A Review of Adapalene in the Treatment of Acne VulgarisJournal of Adolescent Health, 2008
- Topical Retinoids in Acne VulgarisAmerican Journal of Clinical Dermatology, 2008
- Design and evaluation of colon specific drug delivery system containing flurbiprofen microspongesInternational Journal of Pharmaceutics, 2006
- The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studiesInternational Journal of Pharmaceutics, 2006
- AdapaleneDrugs, 2004
- Pharmaceutical Experimental Design (Drugs and the Pharmaceutical Sciences, Vol. 92), Edited by G.A. Lewis, D. Mathieu and R. Phan-Tan-Luu, 1st Edition, Marcel Dekker, New York, 1999. vi+498 pp., 23.5×15.5 cm., 1.9 lb., Hardcover, ISBN 0-8247-9860-0, Price $175.00International Journal of Pharmaceutics, 2000
- Development of oral drug delivery system using floating microspheresJournal of Microencapsulation, 1999
- THE DESIGN OF OPTIMUM MULTIFACTORIAL EXPERIMENTSBiometrika, 1946